Unjha Formulations Ltd share price logo

Unjha Formulations Ltd

BSE: 531762

Small Cap

Pharma Sector

₹30.64

+1.45

(+4.97%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Unjha Formulations Stock Performance

as on September 4, 2026 at 9:31 pm IST

  • Day's Low

    ₹30.50
    ₹30.64
    downward going graph

    0.46%

    Downside

  • 52 Week's Low

    ₹17.52
    ₹30.64
    downward going graph

    42.82%

    Downside

Unjha Formulations share price movements today

Previous Close
₹29.19
Open
₹30.50
Volume
15.13K
Upper Circuit
₹30.64
Lower Circuit
₹27.74
Day's Low - High
₹30.50 - ₹30.64
52 Week Low - High
₹17.52 - ₹30.64

Unjha Formulations Historical Returns

1 Month Return
+ 22.07 %
3 Month Return
+ 44.53 %
1 Year Return
+ 24.96 %
3 Year Return
+ 119.01 %
5 Year Return
+ 240.07 %

Unjha Formulations Fundamentals

as on September 4, 2026 at 4:01 pm IST

Market Cap

₹13.73 Cr

Return on Equity (ROE)

14.97

PE Ratio (TTM)

0

Return on capital employed (ROCE)

20.53

Industry PE ratio

-

Beta (LTM)

0.56

P/B Ratio

2.36

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-58.97

EPS (TTM)

0

Book Value

0

Unjha Formulations Technical Analysis

Track how Unjha Formulations technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish3
Bullish2
Neutral10

Oscillators

Name

Value

Action

MACD level (12,26)
0
Bearish
CCI (20)
35.09
Neutral
RSI (14)
100
Bearish
Momentum (10)
0
Neutral
ADI (14)
100
Neutral
Ultimate Oscillator (7,14,28)
42.86
Neutral

Moving Averages

Name

Value

Action

SMA (20)
30.64
Neutral
EMA (20)
30.64
Neutral
VWMA (20)
30.64
Neutral
SMA (50)
30.64
Neutral
EMA (50)
30.64
Bullish
SMA (200)
30.64
Neutral
EMA (200)
30.57
Bullish
KAMA (200)
30.64
Neutral
DEMA (200)
30.79
Bearish

Unjha Formulations Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Unjha Formulations with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Unjha Formulations Ltd image
Unjha Formulations Ltd
NA13.7348.01%0.00NA15
Alivus Life Sciences Ltd image
Alivus Life Sciences Ltd
BUY16,774.2620.8%0.005642,551
Speciality Medicines Ltd image
Speciality Medicines Ltd
NA131.793.83%0.00858
Medico Intercontinental Ltd image
Medico Intercontinental Ltd
NA26.27-6.51%0.63596
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
HOLD17,469.39-2.59%0.621502,268
See all

Unjha Formulations Stock’s Investor Sentiment and Interest

Search interest for Unjha Formulations Ltd Stock has decreased by -12% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-12% versus previous 30 day period

Unjha Formulations Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
4.76
5.55
4.43
3.95
3.78
3.76
2.37
3.61
4.29
4.41
3.28
3.31
Other Income
0.01
-
0.01
-
0.02
0.01
-
-
0.06
-
-
-
Total Income
4.77
5.54
4.44
3.95
3.81
3.77
2.44
3.63
4.35
4.44
3.33
3.31
Expenses
4.87
5.13
4.37
3.23
3.89
3.52
2.7
3.21
3.5
4.16
3.78
3.11
Operating Profit
-0.11
0.42
0.06
0.72
-0.11
0.24
-0.33
0.4
0.79
0.25
-0.5
0.2
Operating Profit Margin %
-2.31%
7.57%
1.35%
18.23%
-2.91%
6.38%
-13.92%
11.08%
18.41%
5.67%
-15.24%
6.04%
Profit Before Interest, Tax and Depreciation
-0.1
0.41
0.07
0.72
-0.09
0.25
-0.26
0.42
0.85
0.28
-0.45
0.2
Interest
-
-
0.05
-
-
-
-
-
-
-
-
-
Depreciation
0.02
0.02
0.02
0.02
0.02
0.02
0.03
0.03
0.03
0.04
0.04
0.04
Profit Before Tax
-0.12
0.39
0
0.7
-0.11
0.23
-0.29
0.39
0.82
0.24
-0.49
0.16
Tax Paid
-
-
0.18
-
-
-
0.12
-
-
-
0.25
-
Profit After Tax
-0.12
0.39
-0.18
0.7
-0.11
0.22
-0.41
0.39
0.82
0.24
-0.74
0.16
Total Net profit including share of profit / Loss from associate company
-0.12
0.39
-0.18
0.7
-0.11
0.22
-0.41
0.39
0.82
0.24
-0.74
0.16
EPS
0.14
0.87
-0.39
1.56
-0.25
0.5
-0.91
0.87
1.83
0.53
-1.66
0.35
Actual EPS
0.14
0.87
-0.39
1.56
-0.25
0.5
-0.91
0.87
1.83
0.53
-1.66
0.35
Adjusted EPS
0.14
0.87
-0.39
1.56
-0.25
0.5
-0.91
0.87
1.83
0.53
-1.66
0.35
Diluted EPS
0.14
0.87
-0.39
1.56
-0.25
0.5
-0.91
0.87
1.83
0.53
-1.66
0.35

Unjha Formulations Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
11.3
11.42
10.6
9.96
14.16
13.15
18.5
13.86
15.59
Other Income
-
-
0.26
0.22
0.19
0.03
0.01
-
-
Total Income
11.33
11.52
10.86
10.17
14.35
13.18
18.51
13.98
15.75
Expenses
10.95
11.12
10.35
9.81
13.84
12.72
17.92
13.35
14.65
Operating Profit
0.35
0.3
0.25
0.15
0.32
0.43
0.58
0.51
0.94
Operating Profit Margin %
3.1%
2.63%
2.36%
1.51%
2.26%
3.27%
3.14%
3.68%
6.03%
Profit Before Interest, Tax and Depreciation
0.38
0.41
0.5
0.36
0.51
0.46
0.59
0.63
1.1
Interest
0.02
0.02
0.12
0.17
0.13
0.06
0.06
0.01
0.01
Depreciation
0.1
0.09
0.08
0.08
0.08
0.08
0.08
0.1
0.14
Profit Before Tax
0.26
0.3
0.3
0.11
0.3
0.32
0.45
0.52
0.95
Tax Paid
-
-
-
-
0.05
0.05
0.18
0.12
0.25
Profit After Tax
0.26
0.3
0.31
0.1
0.25
0.28
0.28
0.41
0.7
Total Net profit including share of profit / Loss from associate company
0.26
0.3
0.31
0.1
0.25
0.28
0.28
0.41
0.7
EPS
0.58
0.67
0.69
0.23
0.56
0.63
0.62
0.91
1.57
Actual EPS
0.58
0.67
0.69
0.23
0.56
0.63
0.62
0.91
1.57
Adjusted EPS
0.58
0.67
0.69
0.23
0.56
0.63
0.62
0.91
1.57
Diluted EPS
0.58
0.67
0.69
0.23
0.56
0.63
0.62
0.91
1.57

Unjha Formulations Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
0.41
0.39
0.14
-0.12
0.39
-0.7
0.28
-0.26
1.03
-0.04
1.24
Cash Flow from Investing Activities
-0.02
-0.28
0.06
0.04
-0.1
-0.06
-0.02
-0.1
-0.11
-0.18
-0.23
Cash Flow from Financing Activities
-0.4
0.05
-0.05
0.23
-
-
-
-0.06
-0.05
-0.01
-0.01
Net Cash Flow
-0.01
0.15
0.15
0.16
0.29
-0.77
0.25
-0.42
0.86
-0.23
1

Unjha Formulations Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
36.92%
36.92%
36.92%
36.92%
36.92%
36.92%
36.92%
36.92%
36.92%
36.92%
36.92%
Public
63.08%
63.08%
63.08%
63.08%
63.08%
63.08%
63.08%
63.08%
63.08%
63.08%
63.08%
Total Outstanding Shares
44,80,500
44,80,500
44,80,500
44,80,500
44,80,500
44,80,500
44,80,500
44,80,500
44,80,500
44,80,500
44,80,500
Total Shareholders
4,012
3,933
3,985
3,969
4,208
4,273
4,213
4,284
4,251
4,235
4,223

Unjha Formulations Corporate Actions

View detailed summary of the earnings and dividend history of Unjha Formulations.

  • Unjha Formulations Ltd Earnings Results

    Unjha Formulations Ltd’s net profit fell -58.97% since last year same period to ₹0.16Cr in the Q1 2026-2027. On a quarterly growth basis, Unjha Formulations Ltd has generated 121.62% jump in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Unjha Formulations Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, Unjha Formul. stock has moved up by 11.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 168.5% return, outperforming this stock by 73.9%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 36.93% of holdings in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 50.8% return, outperforming this stock by 33.4%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 63.08% of holdings in Jun 2026 quarter

About Unjha Formulations Ltd

Established in June 1987, Unjha Formulations is a manufacturer of pharmaceuticals based in the Mehsana district of Gujarat. It produces a range of human and veterinary products, recently launching 4 new products in 199798, such as Bericof Protobal, NT Formentin Tablets, Nalizole and Isabgol Husk based products. The company has experienced major success in expanding its customer base in India and has even made attempts to export their products to other countries, achieving an export turnover of Rs.0.98 during 199798, with a confirmed export order of Rs.30.00 lacs. Unjha Formulations is one of the largest suppliers of Isabgol in India.

Revenue: ₹3.31Cr as on June 2026 (Q1 FY27)
Net Profit: ₹0.16Cr as on June 2026 (Q1 FY27)
Chairperson Name: Jashodaben S Patel
OrganisationUnjha Formulations Ltd
HeadquartersPatan
IndustryPharmaceuticals
CEOJashodaben S Patel
E-voting on sharesClick here to vote

FAQs

What is Unjha Formulations share price today?

Unjha Formulations share price today stands at ₹30.64 as on at the close of the market. Unjha Formulations share today touched a day high of ₹30.64 and a low of ₹30.5.

What is the 52 week high and 52 week low range for Unjha Formulations share?

Unjha Formulations touched a 52 week high of ₹30.64 and a 52 week low of ₹17.52. Unjha Formulations share price today i.e. is closed at ₹30.64, which is -0.00% down from its 52 week high and 74.89% up from its 52 week low.

What is Unjha Formulations's market capitalisation today?

Unjha Formulations market capitalisation is ₹13.73 Cr as on .

How to buy Unjha Formulations shares?

To buy Unjha Formulations shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 531762 or Unjha Formulations Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Unjha Formulations shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Unjha Formulations trading volume today?

Unjha Formulations trading volume is 15.13K as on . This means that 15.13K shares of Unjha Formulations were bought and sold on the stock market during today's trading session.